Nifty

:

18726.40

Sensex

:

63142.96

127.40 (0.69%)
350.08 (0.56%)

Login

Nifty
Sensex

:
:

18726.40
63142.96

127.40 (0.69%)
350.08 (0.56%)

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

62/99

BSE: 524558 | NSE: NEULANDLAB

Watchlist

NSE BSE

2986.20

07-Jun-2023

Day's Open
Day's High
Day's Low
Previous Close

2915.00
3000.00
2902.15
2912.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

51214
1515.17
3042.00
1005.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,737.73
22.86
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,948.32
0.34%
3.76

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.52
12.52
7.63

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.48
23.11
6.96

PAT CAGR (%)

10 Years
5 Years
3 Years

16.50
39.55
57.90

P:E (Median)

8 Years
5 Years
3 Years

32.70
34.63
28.89

P:BV (Average)

8 Years
5 Years
3 Years

2.93
2.11
2.38

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.60
14.35
13.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 407.07 255.87 59.09% 269.25 236.47 13.86% 293.71 257.85 13.91% 221.17 200.89 10.10%
Expenses 287.36 217.16 32.33% 215.31 204.18 5.45% 224.54 215.06 4.41% 192.69 175.28 9.93%
EBITDA 119.72 38.71 209.27% 53.94 32.29 67.05% 69.17 42.79 61.65% 28.48 25.60 11.25%
EBIDTM 29.41% 15.13% 20.03% 13.66% 23.55% 16.59% 12.88% 12.74%
Other Income 8.06 0.63 1,179.37% 0.93 1.90 -51.05% 0.24 0.29 -17.24% 0.51 2.06 -75.24%
Interest 4.29 2.77 54.87% 2.75 3.32 -17.17% 3.17 3.56 -10.96% 2.86 3.84 -25.52%
Depreciation 13.47 12.45 8.19% 13.34 12.78 4.38% 13.17 11.98 9.93% 12.80 11.83 8.20%
PBT 110.02 24.12 356.14% 38.80 18.10 114.36% 53.06 27.53 92.74% 13.33 11.99 11.18%
Tax 25.51 2.29 1,013.97% 8.36 5.37 55.68% 14.73 7.21 104.30% 3.49 3.34 4.49%
PAT 84.51 21.83 287.13% 30.44 12.73 139.12% 38.33 20.33 88.54% 9.84 8.65 13.76%
PATM 20.76% 8.53% 11.30% 5.38% 13.05% 7.88% 4.45% 4.30%
EPS 66.02 17.05 287.21% 23.78 9.95 138.99% 29.95 15.88 88.60% 7.69 6.76 13.76%

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 407.07 255.87 59.09% 269.25 236.47 13.86% 293.71 257.85 13.91% 221.17 200.89 10.10%
Expenses 287.21 217.00 32.35% 215.17 204.04 5.45% 224.41 215.01 4.37% 192.57 175.20 9.91%
EBITDA 119.86 38.87 208.36% 54.08 32.43 66.76% 69.30 42.83 61.80% 28.60 25.69 11.33%
EBIDTM 29.44% 15.19% 20.09% 13.72% 23.59% 16.61% 12.93% 12.79%
Other Income 8.06 0.63 1,179.37% 0.93 1.90 -51.05% 0.24 0.29 -17.24% 0.51 2.06 -75.24%
Interest 4.29 2.77 54.87% 2.75 3.32 -17.17% 3.17 3.56 -10.96% 2.86 3.84 -25.52%
Depreciation 13.47 12.45 8.19% 13.34 12.78 4.38% 13.17 11.98 9.93% 12.80 11.83 8.20%
PBT 110.16 24.28 353.71% 38.94 18.24 113.49% 53.19 27.58 92.86% 13.46 12.07 11.52%
Tax 25.62 2.50 924.80% 8.39 5.30 58.30% 14.73 7.21 104.30% 3.49 3.34 4.49%
PAT 84.54 21.78 288.15% 30.55 12.94 136.09% 38.46 20.37 88.81% 9.97 8.73 14.20%
PATM 20.77% 8.51% 11.35% 5.47% 13.10% 7.90% 4.51% 4.35%
EPS 65.53 16.88 288.21% 23.68 10.03 136.09% 29.81 15.79 88.79% 7.73 6.77 14.18%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 469.15 465.69 460.59 Net Sales Growth 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% 8.70% 0.74% 1.11% Cost Of Goods Sold 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 243.99 246.53 269.20 Gross Profit 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 225.16 219.16 191.39 GP Margin 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% 47.06% 41.55% Total Expenditure 919.90 808.88 790.47 661.25 608.96 477.38 473.20 430.10 402.79 395.39 403.14 Power & Fuel Cost - 42.21 39.21 32.75 26.81 25.95 25.78 22.24 22.53 18.31 18.97 % Of Sales - 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% 3.93% 4.12% Employee Cost - 175.76 144.02 118.48 104.47 95.73 84.92 59.89 49.16 36.26 34.88 % Of Sales - 18.48% 15.37% 15.53% 15.67% 18.15% 14.67% 11.74% 10.48% 7.79% 7.57% Manufacturing Exp. - 89.16 77.10 64.84 50.10 55.54 44.90 39.31 43.56 40.98 35.86 % Of Sales - 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% 8.80% 7.79% General & Admin Exp. - 34.50 37.42 25.18 24.56 30.38 25.23 26.90 20.77 14.50 14.43 % Of Sales - 3.63% 3.99% 3.30% 3.68% 5.76% 4.36% 5.27% 4.43% 3.11% 3.13% Selling & Distn. Exp. - 36.00 42.38 26.59 28.01 26.50 23.14 26.41 20.31 33.64 21.35 % Of Sales - 3.79% 4.52% 3.49% 4.20% 5.02% 4.00% 5.18% 4.33% 7.22% 4.64% Miscellaneous Exp. - 9.12 11.93 13.21 8.76 4.91 6.34 1.89 2.47 5.17 21.35 % Of Sales - 0.96% 1.27% 1.73% 1.31% 0.93% 1.10% 0.37% 0.53% 1.11% 1.83% EBITDA 271.31 142.20 146.44 101.46 57.87 50.03 105.69 79.87 66.36 70.30 57.45 EBITDA Margin 22.78% 14.95% 15.63% 13.30% 8.68% 9.49% 18.26% 15.66% 14.14% 15.10% 12.47% Other Income 9.74 2.08 16.09 3.89 3.49 4.53 1.17 1.62 0.78 3.41 4.00 Interest 13.07 13.49 17.90 21.57 15.66 18.92 21.08 24.47 27.35 24.55 31.33 Depreciation 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 15.32 14.94 14.62 PBT 215.21 81.74 104.96 52.50 19.84 13.54 66.55 41.28 24.48 34.22 15.50 Tax 52.09 18.21 24.67 36.62 3.69 1.73 20.17 14.87 8.70 7.56 1.86 Tax Rate 24.20% 22.28% 23.50% 69.75% 18.60% 12.78% 30.31% 36.02% 35.54% 22.09% 12.00% PAT 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 15.78 26.67 13.64 PAT before Minority Interest 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 15.78 26.67 13.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.69% 6.68% 8.57% 2.08% 2.42% 2.24% 8.01% 5.18% 3.36% 5.73% 2.96% PAT Growth 156.72% -20.87% 405.60% -1.61% 36.66% -74.54% 75.62% 67.36% -40.83% 95.53% EPS 127.44 49.63 62.73 12.41 12.61 9.23 36.23 20.63 12.33 20.84 10.66

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 469.15 465.69 460.59 Net Sales Growth 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% 8.70% 0.74% 1.11% Cost Of Goods Sold 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 243.99 246.53 269.20 Gross Profit 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 225.16 219.16 191.39 GP Margin 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% 47.06% 41.55% Total Expenditure 919.36 808.46 790.09 660.82 608.46 476.98 472.55 429.52 402.53 395.08 402.91 Power & Fuel Cost - 42.21 39.21 32.75 26.81 25.95 25.78 22.24 22.53 18.31 18.97 % Of Sales - 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% 3.93% 4.12% Employee Cost - 182.47 149.74 123.56 110.46 102.99 92.74 65.38 51.81 41.74 40.75 % Of Sales - 19.19% 15.98% 16.20% 16.56% 19.53% 16.02% 12.82% 11.04% 8.96% 8.85% Manufacturing Exp. - 89.16 77.10 64.84 50.10 55.54 44.90 39.31 43.56 40.98 35.86 % Of Sales - 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% 8.80% 7.79% General & Admin Exp. - 35.80 38.93 27.75 27.49 33.32 28.30 29.72 23.59 15.95 16.27 % Of Sales - 3.76% 4.16% 3.64% 4.12% 6.32% 4.89% 5.83% 5.03% 3.43% 3.53% Selling & Distn. Exp. - 27.40 34.63 18.30 18.28 14.04 11.16 17.52 14.54 26.57 13.51 % Of Sales - 2.88% 3.70% 2.40% 2.74% 2.66% 1.93% 3.44% 3.10% 5.71% 2.93% Miscellaneous Exp. - 9.28 12.08 13.42 9.08 6.77 6.78 1.89 2.52 4.99 13.51 % Of Sales - 0.98% 1.29% 1.76% 1.36% 1.28% 1.17% 0.37% 0.54% 1.07% 1.81% EBITDA 271.84 142.62 146.82 101.89 58.37 50.43 106.34 80.45 66.62 70.61 57.68 EBITDA Margin 22.82% 15.00% 15.67% 13.36% 8.75% 9.56% 18.37% 15.78% 14.20% 15.16% 12.52% Other Income 9.74 2.08 16.10 3.89 3.49 4.53 1.17 1.78 0.78 3.44 4.06 Interest 13.07 13.50 17.90 21.57 15.66 18.93 21.09 24.48 27.36 24.56 31.33 Depreciation 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 15.32 14.94 14.62 PBT 215.75 82.16 105.33 52.92 20.34 13.93 67.19 42.00 24.72 34.55 15.78 Tax 52.23 18.34 24.70 36.71 3.90 1.87 20.32 14.92 8.79 7.80 1.96 Tax Rate 24.21% 22.32% 23.45% 69.37% 19.17% 13.42% 30.24% 35.52% 35.56% 22.58% 12.42% PAT 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.33 15.94 26.80 13.86 PAT before Minority Interest 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.08 15.93 26.75 13.82 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.01 0.05 0.04 PAT Margin 13.73% 6.71% 8.61% 2.13% 2.47% 2.29% 8.09% 5.36% 3.40% 5.75% 3.01% PAT Growth 156.22% -20.85% 397.41% -1.40% 36.32% -74.26% 71.46% 71.46% -40.52% 93.36% EPS 127.75 49.86 62.99 12.66 12.84 9.42 36.61 21.35 12.45 20.94 10.83

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 835.57 781.88 705.55 695.58 554.78 542.78 184.17 159.83 122.60 98.58 Share Capital 12.90 12.90 12.90 12.90 8.95 8.95 8.95 8.95 7.73 7.72 Total Reserves 822.67 768.98 692.64 682.68 234.98 222.97 175.22 150.87 114.87 90.87 Non-Current Liabilities 178.42 168.68 162.21 103.13 145.78 53.83 69.01 54.58 52.20 61.85 Secured Loans 104.25 88.13 77.37 60.72 103.49 29.81 33.40 21.22 8.87 26.11 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 12.00 12.00 25.00 25.00 Long Term Provisions 11.45 9.10 12.18 11.74 9.87 9.28 6.85 6.38 5.14 4.71 Current Liabilities 368.13 372.96 361.99 331.19 370.38 288.24 270.16 296.76 308.46 264.23 Trade Payables 117.54 156.75 120.00 124.00 129.01 88.64 86.17 111.76 93.37 81.49 Other Current Liabilities 157.16 158.59 71.55 57.33 40.57 47.11 54.90 33.16 66.15 42.62 Short Term Borrowings 92.21 56.98 168.17 149.06 199.20 151.08 123.63 145.80 139.62 132.47 Short Term Provisions 1.21 0.64 2.27 0.80 1.59 1.41 5.47 6.04 9.33 7.65 Total Liabilities 1,382.12 1,323.52 1,229.75 1,129.90 1,070.94 884.85 523.34 511.17 483.26 424.66 Net Block 747.70 696.92 622.75 511.67 445.01 435.74 138.77 123.07 130.85 135.52 Gross Block 919.60 826.45 714.31 575.42 483.45 454.74 291.78 263.65 258.54 250.39 Accumulated Depreciation 171.90 129.53 91.56 63.75 38.44 19.00 153.00 140.58 127.69 114.87 Non Current Assets 800.89 775.34 715.91 676.96 624.22 510.60 210.00 196.04 196.38 198.10 Capital Work in Progress 20.46 17.25 23.75 104.47 126.09 19.60 40.48 41.47 34.56 35.69 Non Current Investment 20.31 19.50 30.33 30.37 30.37 30.36 7.55 7.67 7.64 7.64 Long Term Loans & Adv. 12.42 41.66 35.78 30.45 22.52 24.69 22.71 23.83 23.32 11.16 Other Non Current Assets 0.00 0.00 3.30 0.00 0.22 0.22 0.50 0.00 0.00 8.09 Current Assets 581.23 548.18 513.83 452.93 446.73 374.24 313.34 315.13 286.89 226.56 Current Investments 3.38 6.46 7.50 7.50 7.50 7.50 0.00 0.00 0.00 0.00 Inventories 265.21 247.61 219.55 192.65 175.09 135.11 126.66 113.40 93.42 92.17 Sundry Debtors 234.33 217.73 189.89 164.02 193.92 181.11 119.11 128.85 118.59 98.50 Cash & Bank 18.99 18.08 45.69 37.35 17.05 12.04 9.04 6.49 6.68 0.28 Other Current Assets 59.33 8.76 17.42 19.64 53.17 38.47 58.53 66.39 68.19 35.61 Short Term Loans & Adv. 47.94 49.54 33.79 31.77 36.93 25.03 46.54 45.17 42.73 25.80 Net Current Assets 213.11 175.22 151.84 121.74 76.35 86.00 43.18 18.37 -21.58 -37.67 Total Assets 1,382.12 1,323.52 1,229.74 1,129.89 1,070.95 884.84 523.34 511.17 483.27 424.66

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 840.50 786.46 709.96 699.31 558.04 545.62 186.63 161.38 123.99 99.83 Share Capital 12.90 12.90 12.90 12.90 8.95 8.95 8.95 8.95 7.73 7.72 Total Reserves 827.60 773.56 697.06 686.41 238.24 225.81 177.68 152.42 116.26 92.12 Non-Current Liabilities 179.83 169.82 163.39 104.06 146.43 54.37 69.42 54.76 52.33 61.85 Secured Loans 104.25 88.13 77.37 60.72 103.49 29.81 33.40 21.22 8.87 26.11 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 12.00 12.00 25.00 25.00 Long Term Provisions 11.91 9.44 12.49 11.91 9.87 9.28 6.85 6.38 5.14 4.71 Current Liabilities 363.16 368.51 357.63 326.98 366.93 285.60 268.00 295.14 306.90 262.99 Trade Payables 112.27 152.13 115.56 119.68 124.29 85.92 83.86 111.81 93.94 82.02 Other Current Liabilities 157.46 158.75 71.63 57.45 41.83 47.18 55.02 31.28 63.74 40.46 Short Term Borrowings 92.21 56.98 168.17 149.06 199.20 151.08 123.63 145.80 139.62 132.68 Short Term Provisions 1.21 0.64 2.27 0.80 1.59 1.41 5.50 6.25 9.61 7.83 Total Liabilities 1,383.49 1,324.79 1,230.98 1,130.35 1,071.40 885.59 524.05 511.53 483.48 424.98 Net Block 747.70 696.94 622.76 511.69 445.01 435.74 138.77 123.07 130.85 135.52 Gross Block 919.62 826.48 714.33 575.44 483.45 454.74 291.78 263.65 258.54 250.39 Accumulated Depreciation 171.92 129.54 91.57 63.75 38.44 19.00 153.00 140.58 127.69 114.87 Non Current Assets 800.71 775.20 715.79 676.88 624.20 510.54 209.87 195.76 195.93 197.66 Capital Work in Progress 20.46 17.25 23.75 104.47 126.09 19.60 40.48 41.47 34.56 35.69 Non Current Investment 20.16 19.35 30.17 30.21 30.21 30.20 7.39 7.39 7.36 7.36 Long Term Loans & Adv. 12.40 41.67 35.81 30.51 22.66 24.79 22.73 23.83 23.15 10.99 Other Non Current Assets 0.00 0.00 3.30 0.00 0.22 0.22 0.50 0.00 0.00 8.09 Current Assets 582.78 549.59 515.19 453.47 447.19 375.04 314.19 315.77 287.55 227.32 Current Investments 3.38 6.46 7.50 7.50 7.50 7.50 0.00 0.00 0.00 0.00 Inventories 265.21 247.61 219.55 192.65 175.09 135.11 126.66 113.40 93.42 92.17 Sundry Debtors 234.33 217.73 189.89 164.02 193.92 181.11 119.11 128.85 118.59 98.50 Cash & Bank 20.36 19.40 46.98 37.84 17.26 12.49 9.71 6.98 7.07 1.18 Other Current Assets 59.50 8.84 17.47 19.69 53.43 38.83 58.70 66.53 68.47 35.48 Short Term Loans & Adv. 47.98 49.55 33.80 31.77 37.15 25.30 46.68 45.23 43.01 25.66 Net Current Assets 219.62 181.08 157.55 126.49 80.27 89.45 46.18 20.63 -19.35 -35.66 Total Assets 1,383.49 1,324.79 1,230.98 1,130.35 1,071.39 885.58 524.06 511.53 483.48 424.98

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 58.60 189.28 56.63 69.60 11.52 38.89 44.65 13.07 48.53 26.16 PBT 81.74 104.96 52.50 19.84 13.54 66.55 41.28 24.48 34.22 15.50 Adjustment 64.37 40.17 58.14 38.93 40.35 43.95 33.85 36.35 34.39 42.26 Changes in Working Capital -66.99 49.34 -49.30 15.92 -39.20 -55.25 -18.76 -38.74 -16.75 -30.81 Cash after chg. in Working capital 79.12 194.47 61.33 74.68 14.69 55.25 56.38 22.08 51.86 26.95 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -20.53 -5.19 -4.70 -5.09 -3.17 -16.36 -11.73 -9.01 -3.33 -0.79 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -93.72 -84.42 -48.68 -77.22 -116.29 -42.11 -19.86 -14.13 -9.78 -7.22 Net Fixed Assets -96.36 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 -7.02 -4.86 Net Investments 2.27 11.87 0.04 0.00 -0.01 -30.31 0.12 -0.03 0.00 0.03 Others 0.37 9.35 9.45 -6.87 18.92 130.28 7.16 -2.08 -2.76 -2.39 Cash from Financing Activity 37.72 -113.66 -5.48 11.98 104.86 -0.08 -23.62 1.15 -38.74 -20.16 Net Cash Inflow / Outflow 2.60 -8.80 2.47 4.36 0.09 -3.30 1.18 0.08 0.00 -1.22 Opening Cash & Equivalents 1.12 9.92 7.44 3.08 3.00 6.29 0.32 0.23 0.23 1.45 Closing Cash & Equivalent 3.72 1.12 9.92 7.44 3.08 3.00 1.49 0.32 0.23 0.23

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 58.58 189.36 57.34 69.91 11.27 38.68 44.83 13.17 48.77 25.83 PBT 82.16 105.33 52.92 20.34 13.93 67.19 42.00 24.72 34.55 15.78 Adjustment 64.50 40.08 58.28 39.11 40.43 43.96 33.73 36.34 34.37 42.22 Changes in Working Capital -67.58 49.22 -49.17 15.47 -40.02 -55.94 -19.17 -38.76 -16.82 -31.35 Cash after chg. in Working capital 79.07 194.63 62.03 74.91 14.35 55.20 56.56 22.30 52.11 26.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -20.49 -5.27 -4.68 -5.01 -3.08 -16.52 -11.73 -9.13 -3.34 -0.82 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -93.71 -84.42 -48.68 -77.23 -116.29 -42.11 -19.86 -14.13 -9.84 -7.22 Net Fixed Assets -96.36 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 -7.02 -4.86 Net Investments 2.27 11.87 0.04 0.00 -0.01 -30.31 0.12 -0.03 0.00 0.03 Others 0.38 9.35 9.45 -6.88 18.92 130.28 7.16 -2.08 -2.82 -2.39 Cash from Financing Activity 37.72 -113.66 -5.48 11.98 104.85 -0.09 -23.62 1.15 -38.96 -19.90 Net Cash Inflow / Outflow 2.59 -8.72 3.18 4.66 -0.17 -3.51 1.35 0.19 -0.03 -1.28 Opening Cash & Equivalents 2.44 11.20 7.94 3.29 3.44 6.97 0.81 0.62 0.65 1.93 Closing Cash & Equivalent 5.09 2.44 11.20 7.94 3.29 3.44 2.16 0.81 0.62 0.65

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 650.56 608.71 549.21 541.45 273.54 260.03 206.30 178.97 151.75 121.84 ROA 4.70% 6.29% 1.35% 1.47% 1.21% 6.59% 5.11% 3.17% 5.87% 3.22% ROE 7.86% 10.81% 2.27% 3.44% 4.98% 22.39% 15.44% 11.25% 24.35% 15.92% ROCE 9.44% 12.83% 7.84% 3.95% 4.04% 15.94% 18.46% 15.74% 18.97% 15.55% Fixed Asset Turnover 1.09 1.22 1.18 1.26 1.13 1.57 1.86 1.82 1.87 1.86 Receivable days 86.74 79.40 84.68 97.96 129.34 93.22 87.45 94.81 83.45 75.67 Inventory Days 98.40 91.00 98.63 100.64 106.98 81.29 84.66 79.24 71.34 71.66 Payable days 118.58 115.20 67.56 78.05 84.05 68.43 85.33 91.74 81.35 87.51 Cash Conversion Cycle 66.57 55.20 115.76 120.56 152.27 106.08 86.78 82.31 73.45 59.82 Total Debt/Equity 0.28 0.22 0.37 0.33 1.31 0.83 0.99 1.18 1.56 2.16 Interest Cover 7.06 6.86 3.43 2.27 1.72 4.16 2.69 1.90 2.39 1.49

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 654.40 612.28 552.65 544.35 277.21 263.23 209.07 180.72 153.48 123.40 ROA 4.71% 6.31% 1.37% 1.49% 1.23% 6.65% 5.23% 3.20% 5.89% 3.26% ROE 7.85% 10.79% 2.30% 3.48% 5.02% 22.34% 15.64% 11.24% 24.14% 15.92% ROCE 9.44% 12.81% 7.85% 3.99% 4.07% 15.98% 18.57% 15.75% 18.99% 15.58% Fixed Asset Turnover 1.09 1.22 1.18 1.26 1.13 1.57 1.86 1.82 1.87 1.86 Receivable days 86.74 79.40 84.68 97.96 129.34 93.22 87.45 94.81 83.45 75.67 Inventory Days 98.40 91.00 98.63 100.64 106.98 81.29 84.66 79.24 71.34 71.66 Payable days 114.31 111.44 65.43 75.72 82.06 67.03 85.01 92.70 82.14 88.22 Cash Conversion Cycle 70.84 58.96 117.88 122.89 154.27 107.48 87.10 81.35 72.66 59.11 Total Debt/Equity 0.28 0.22 0.37 0.33 1.30 0.82 0.98 1.17 1.55 2.13 Interest Cover 7.09 6.89 3.45 2.30 1.74 4.19 2.72 1.90 2.41 1.50

Top Investors:

malabar india fund limited

matthews india fund

malabar value fund

mukul mahavir agrawal

kedia securities private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

USFDA completes inspection at Unit 3 manufacturing facility of Neuland Laboratories
27th May 2023, 16:40 PM

The inspection has been concluded with 3 observations (minor) given under form 483
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback